{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:44:21Z","timestamp":1789685061513,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.carrev.2024.05.027","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:53:48Z","timestamp":1716486828000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Drug-coated balloons for coronary artery disease: An updated review with future perspectives"],"prefix":"10.1016","volume":"69","author":[{"given":"Sukhdeep","family":"Bhogal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Merdler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Wermers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsik","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2024.05.027_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0735-1097(91)90783-6","article-title":"Restenosis after coronary angioplasty: a multilvariate statistical model to relate lesion and procedure variables to restenosis","volume":"18","author":"Hirshfeld","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0025","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"A cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.05.027_bb0030","first-page":"316","article-title":"Remodeling and restenosis: observations from serial intravascular ultrasound studies","volume":"2","author":"Mintz","year":"2000","journal-title":"Curr Interv Cardiol Rep"},{"key":"10.1016\/j.carrev.2024.05.027_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0021-9150(01)00618-9","article-title":"Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials","volume":"160","author":"Gershlick","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2024.05.027_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00392-016-1019-4","article-title":"Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography","volume":"106","author":"Poerner","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147057","article-title":"Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: serial IVUS-VH and FFR study","volume":"11","author":"Ann","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.carrev.2024.05.027_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0055","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0735-1097(00)00614-8","article-title":"Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo","volume":"35","author":"Herdeg","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl K","key":"10.1016\/j.carrev.2024.05.027_bb0060","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.4244\/EIJV7SKA4","article-title":"Local drug delivery - the early Berlin experience: single drug administration versus sustained release","volume":"7","author":"Speck","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.05.027_bb0070","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4244\/EIJV7I6A116","article-title":"Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients","volume":"7","author":"Radke","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0075","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0080","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0085","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.104.8.852","article-title":"Bench to bedside: the development of rapamycin and its application to stent restenosis","volume":"104","author":"Marx","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.05.027_bb0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2005.09.047","article-title":"Sirolimus and paclitaxel on polymer-based drug-eluting stents: similar but different","volume":"47","author":"Wessely","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.carrev.2022.08.037","article-title":"Sirolimus-coated balloon with a microsphere-based technology for the treatment of de novo or restenotic coronary lesions","volume":"45","author":"Costa","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4244\/EIJV9I1A21","article-title":"Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter","volume":"9","author":"Lemos Alves","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0105","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","article-title":"A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in de novo small vessels","volume":"16","author":"Ninomiya","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0110","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.msec.2013.06.021","article-title":"Novel paclitaxel-coated angioplasty balloon catheter based on cetylpyridinium salicylate: preparation, characterization and simulated use in an in vitro vessel model","volume":"33","author":"Petersen","year":"2013","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.carrev.2024.05.027_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvir.2018.07.025","article-title":"Comparison of biologic effect and particulate embolization after femoral artery treatment with three drug-coated balloons in healthy swine model","volume":"30","author":"Torii","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0120","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.amjcard.2016.08.006","article-title":"Impact of angiographic result after predilatation on outcome after drug-coated balloon treatment of in-stent coronary restenosis","volume":"118","author":"Tanaka","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","article-title":"Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group","volume":"102","author":"Kleber","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0130","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial","volume":"10","author":"Kufner","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijcard.2021.07.019","article-title":"Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment","volume":"339","author":"Ishihara","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.carrev.2018.02.007","article-title":"Stent-less percutaneous coronary intervention using rotational atherectomy and drug-coated balloon: a case series and a mini review","volume":"19","author":"Shiraishi","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0145","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.brachy.2021.04.002","article-title":"Intravascular coronary brachytherapy combined with a drug-coated balloon","volume":"20","author":"Kearney","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.carrev.2024.05.027_bb0150","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4244\/EIJ-D-18-01013","article-title":"Impact of adjunctive use of guide extension catheter on midterm outcome of drug-coated balloon angioplasty","volume":"15","author":"Ruka","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0155","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0160","article-title":"How to use the drug-eluting balloon: recommendations by the German consensus group","volume":"7","author":"Franz-Xaver","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0165","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-E-23-00034","article-title":"Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons","volume":"20","author":"Colombo","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0170","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"5","author":"Scheller","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0180","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.05.027_bb0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcin.2013.08.011","article-title":"A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis","volume":"7","author":"Xu","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2024.05.027_bb0195","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurheartj\/ehad026","article-title":"Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial","volume":"44","author":"Giacoppo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.05.027_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2017.11.008","article-title":"Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: a randomized RESTORE trial","volume":"197","author":"Wong","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2024.05.027_bb0215","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.05.027_bb0220","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0225","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.05.027_bb0230","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jcin.2016.03.025","article-title":"Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis","volume":"9","author":"Siontis","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0235","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0240","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-coated balloon versus drug-eluting stent for small-vessel disease","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0245","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2024.05.027_bb0250","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jcin.2015.04.008","article-title":"3-Year follow-up of the balloon elution and late loss optimization study (BELLO)","volume":"8","author":"Latib","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4244\/EIJV9I5A98","article-title":"Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial","volume":"9","author":"Waksman","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ccd.27724","article-title":"Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: the DCB-only All-Comers Registry","volume":"93","author":"Rosenberg","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/ccd.27548","article-title":"Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions","volume":"92","author":"Venetsanos","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0270","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00392-020-01734-6","article-title":"Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study","volume":"110","author":"Merinopoulos","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0275","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3349\/ymj.2016.57.3.606","article-title":"Serial morphological changes of side-branch ostium after paclitaxel-coated balloon treatment of de novo coronary lesions of main vessels","volume":"57","author":"Her","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.carrev.2024.05.027_bb0280","article-title":"Feasibility and safety of drug-coated balloon-only angioplasty for de novo ostial lesions of the left anterior descending artery: two-center retrospective study","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0285","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4244\/EIJV10I5A101","article-title":"Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study","volume":"10","author":"Nicola","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0290","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4330\/wjc.v7.i6.311","article-title":"Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention","volume":"7","author":"Ho","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0295","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.amjms.2017.07.005","article-title":"Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study","volume":"354","author":"Gobi\u0107","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.carrev.2024.05.027_bb0300","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0305","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0310","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2004.07.060","article-title":"New aspects in the pathogenesis of diabetic atherothrombosis","volume":"44","author":"Moreno","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12872-016-0433-x","article-title":"Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome","volume":"16","author":"Kukula","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2024.05.027_bb0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.carrev.2012.06.001","article-title":"One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the DiabEtic Argentina Registry (DEAR)","volume":"13","author":"Mieres","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0325","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ccd.27950","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: an all-comers registry study","volume":"93","author":"Uskela","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0330","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2024.05.027_bb0335","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011569","article-title":"Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial","volume":"15","author":"Scheller","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2018.08.2006","article-title":"TCT-776 duration of dual antiplatelet therapy after drug-coated balloon implantation","volume":"72","author":"Kleber","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl K","key":"10.1016\/j.carrev.2024.05.027_bb0345","doi-asserted-by":"crossref","first-page":"K61","DOI":"10.4244\/EIJV7SKA11","article-title":"Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial","volume":"7","author":"Mathey","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0350","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carrev.2015.07.009","article-title":"Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study","volume":"16","author":"Worthley","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0355","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","article-title":"Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial","volume":"105","author":"Kleber","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251986","article-title":"Drug coated balloons for coronary artery bifurcation lesions: a systematic review and focused meta-analysis","volume":"16","author":"Corballis","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.carrev.2024.05.027_bb0365","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"Dangas","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0370","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00392-012-0415-7","article-title":"Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter","volume":"101","author":"Cremers","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0375","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003543","article-title":"Novel sirolimus\u2013coated balloon catheter","volume":"9","author":"Clever","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0380","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2459\/JCM.0000000000001070","article-title":"Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry","volume":"22","author":"Cortese","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.carrev.2024.05.027_bb0385","doi-asserted-by":"crossref","first-page":"E496","DOI":"10.1002\/ccd.28863","article-title":"Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolut\u00e8 study","volume":"96","author":"El-Mokdad","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ccd.28998","article-title":"Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population","volume":"98","author":"Basavarajaiah","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8865223","article-title":"Sirolimus-eluting balloon for the treatment of coronary lesions in complex ACS patients: the SELFIE registry","volume":"2020","author":"Caiazzo","year":"2020","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2021.04.013","article-title":"Comparison between sirolimus- and paclitaxel-coated balloon for revascularization of coronary arteries: the SIRPAC (SIRolimus-PAClitaxel) study","volume":"28","author":"Cortese","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0405","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon","volume":"12","author":"Ali","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0410","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012305","article-title":"Combined analysis of two parallel randomized trials of sirolimus-coated and paclitaxel-coated balloons in coronary in-stent restenosis lesions","volume":"15","author":"Scheller","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0415","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","article-title":"Treatment of coronary de novo lesions by a sirolimus- or paclitaxel-coated balloon","volume":"15","author":"Ahmad","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0420","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jcin.2017.06.021","article-title":"The SABRE trial (sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes","volume":"10","author":"Verheye","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0425","doi-asserted-by":"crossref","first-page":"906","DOI":"10.5603\/CJ.a2022.0106","article-title":"Metal free percutaneous coronary interventions in all-comers: first experience with a novel sirolimus-coated balloon","volume":"29","author":"Madanchi","year":"2022","journal-title":"Cardiol J"},{"key":"10.1016\/j.carrev.2024.05.027_bb0430","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ccd.30358","article-title":"Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial","volume":"100","author":"Greco","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0435","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcin.2022.03.024","article-title":"Biolimus-coated balloon in small-vessel coronary artery disease","volume":"15","author":"Xu","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0440","series-title":"Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis","author":"EuroPCR 2023","year":"2023"},{"key":"10.1016\/j.carrev.2024.05.027_bb0445","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent\u2013in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0450","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4244\/EIJV10I4A77","volume":"10","author":"Adrianssens","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0455","article-title":"Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis","volume":"9","author":"Pleva","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.05.027_bb0460","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis","volume":"59","author":"Rittger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0465","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4244\/EIJ-D-17-01079","article-title":"Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial","volume":"14","author":"Jensen","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2024.05.027_bb0470","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study","volume":"96","author":"Cortese","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2024.05.027_bb0475","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-018-1346-8","article-title":"Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute","volume":"108","author":"Yu","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0480","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2016.07.156","article-title":"Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease","volume":"222","author":"Nishiyama","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0485","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.carrev.2017.03.025","article-title":"Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry","volume":"18","author":"Cortese","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.carrev.2018.06.003","article-title":"A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-month data from the Nanolut\u00e9 Registry","volume":"20","author":"Dani","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.05.027_bb0495","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2459\/JCM.0000000000000806","article-title":"Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry","volume":"20","author":"Cortese","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.carrev.2024.05.027_bb0500","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ijcard.2016.08.133","article-title":"Angiographic result of sirolimus-eluting balloon in de novo small coronary artery lesion (ARSENAL)","volume":"222","author":"Jim","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2024.05.027_bb0505","first-page":"327","article-title":"Paclitexel versus sirolimus-coated balloon in the treatment of coronary instent restenosis","volume":"65","author":"Briguori","year":"2021","journal-title":"Panminerva Med"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924004962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924004962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:29:49Z","timestamp":1733790589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924004962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":101,"alternative-id":["S1553838924004962"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.05.027","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-coated balloons for coronary artery disease: An updated review with future perspectives","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}